Literature DB >> 28523882

Phacomatosis Pigmentokeratotica: A Mosaic RASopathy with Malignant Potential.

Amit Om1, Sara S Cathey2, Robert M Gathings3, Michelle Hudspeth4, Jennifer A Lee2, Sean Marzolf3, Lara Wine Lee3.   

Abstract

Phacomatosis pigmentokeratotica (PPK) is a rare epidermal nevus syndrome characterized by the co-occurrence of a nevus sebaceous arranged along the lines of Blaschko with a speckled lentiginous nevus (SLN). We report a novel KRAS mutation in a patient with a large nevus sebaceous and an SLN who subsequently developed a vaginal botryoid rhabdomyosarcoma, an association not previously reported in the literature. This case expands our knowledge of the genetic basis for phacomatosis, in which mutations in HRAS have been previously described, although this report provides evidence that activating mutations in KRAS or HRAS may cause PPK. This report confirms that PPK is a mosaic RASopathy with malignant potential and raises the question of whether screening for other RAS-associated malignancies should be performed for all children with PPK.
© 2017 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28523882     DOI: 10.1111/pde.13119

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  2 in total

1.  Classification of KRAS-Activating Mutations and the Implications for Therapeutic Intervention.

Authors:  Christian Johnson; Deborah L Burkhart; Kevin M Haigis
Journal:  Cancer Discov       Date:  2022-04-01       Impact factor: 38.272

2.  Phacomatosis pigmentokeratotica without extracutaneous abnormalities: 12-year follow-up.

Authors:  Claire E Hannah; Jaclyn R Keller; Megan H Noe; Jennifer R S Gordon; Emily K Fridlington; Roger I Ceilley; Vincent Liu
Journal:  JAAD Case Rep       Date:  2019-11-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.